Is Alphabet Stock No Longer a Good Bet?
Alphabet tripled its price per share over the past 5…
Sell
26
FBT Quote, Financials, Valuation and Earnings
Last price:
$168.00
Seasonality move
:
4.16%
Day range:
$168.06 - $169.70
52-week range:
$140.36 - $183.60
Dividend yield:
0.7%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
12.7K
Avg. volume:
24.4K
1-year change:
11.04%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
-- | -- | -- | -- | -- |
|
IBB
iShares Biotechnology ETF
|
-- | -- | -- | -- | -- |
|
IBBQ
Invesco Nasdaq Biotechnology ETF
|
-- | -- | -- | -- | -- |
|
IHI
iShares US Medical Devices ETF
|
-- | -- | -- | -- | -- |
|
IYH
iShares US Healthcare ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
$168.06 | -- | -- | -- | $1.17 | 0.7% | -- |
|
IBB
iShares Biotechnology ETF
|
$134.09 | -- | -- | -- | $0.12 | 0.29% | -- |
|
IBBQ
Invesco Nasdaq Biotechnology ETF
|
$22.17 | -- | -- | -- | $0.06 | 1.11% | -- |
|
IHI
iShares US Medical Devices ETF
|
$59.52 | -- | -- | -- | $0.03 | 0.46% | -- |
|
IYH
iShares US Healthcare ETF
|
$61.16 | -- | -- | -- | $0.16 | 1.18% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
-- | 1.243 | -- | -- |
|
IBB
iShares Biotechnology ETF
|
-- | 1.306 | -- | -- |
|
IBBQ
Invesco Nasdaq Biotechnology ETF
|
-- | 1.162 | -- | -- |
|
IHI
iShares US Medical Devices ETF
|
-- | 1.267 | -- | -- |
|
IYH
iShares US Healthcare ETF
|
-- | -0.715 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
-- | -- | -- | -- | -- | -- |
|
IBB
iShares Biotechnology ETF
|
-- | -- | -- | -- | -- | -- |
|
IBBQ
Invesco Nasdaq Biotechnology ETF
|
-- | -- | -- | -- | -- | -- |
|
IHI
iShares US Medical Devices ETF
|
-- | -- | -- | -- | -- | -- |
|
IYH
iShares US Healthcare ETF
|
-- | -- | -- | -- | -- | -- |
First Trust NYSE Arca Biotechnology Index Fund vs. Competitors
-
Which has Higher Returns FBT or IBB?
iShares Biotechnology ETF has a net margin of -- compared to First Trust NYSE Arca Biotechnology Index Fund's net margin of --. First Trust NYSE Arca Biotechnology Index Fund's return on equity of -- beat iShares Biotechnology ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital FBTFirst Trust NYSE Arca Biotechnology Index Fund-- -- -- IBBiShares Biotechnology ETF-- -- -- -
What do Analysts Say About FBT or IBB?
First Trust NYSE Arca Biotechnology Index Fund has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares Biotechnology ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that First Trust NYSE Arca Biotechnology Index Fund has higher upside potential than iShares Biotechnology ETF, analysts believe First Trust NYSE Arca Biotechnology Index Fund is more attractive than iShares Biotechnology ETF.
Company Buy Ratings Hold Ratings Sell Ratings FBTFirst Trust NYSE Arca Biotechnology Index Fund0 0 0 IBBiShares Biotechnology ETF0 0 0 -
Is FBT or IBB More Risky?
First Trust NYSE Arca Biotechnology Index Fund has a beta of 0.732, which suggesting that the stock is 26.822% less volatile than S&P 500. In comparison iShares Biotechnology ETF has a beta of 0.794, suggesting its less volatile than the S&P 500 by 20.628%.
-
Which is a Better Dividend Stock FBT or IBB?
First Trust NYSE Arca Biotechnology Index Fund has a quarterly dividend of $1.17 per share corresponding to a yield of 0.7%. iShares Biotechnology ETF offers a yield of 0.29% to investors and pays a quarterly dividend of $0.12 per share. First Trust NYSE Arca Biotechnology Index Fund pays -- of its earnings as a dividend. iShares Biotechnology ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios FBT or IBB?
First Trust NYSE Arca Biotechnology Index Fund quarterly revenues are --, which are smaller than iShares Biotechnology ETF quarterly revenues of --. First Trust NYSE Arca Biotechnology Index Fund's net income of -- is lower than iShares Biotechnology ETF's net income of --. Notably, First Trust NYSE Arca Biotechnology Index Fund's price-to-earnings ratio is -- while iShares Biotechnology ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for First Trust NYSE Arca Biotechnology Index Fund is -- versus -- for iShares Biotechnology ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income FBTFirst Trust NYSE Arca Biotechnology Index Fund-- -- -- -- IBBiShares Biotechnology ETF-- -- -- --
-
Which has Higher Returns FBT or IBBQ?
Invesco Nasdaq Biotechnology ETF has a net margin of -- compared to First Trust NYSE Arca Biotechnology Index Fund's net margin of --. First Trust NYSE Arca Biotechnology Index Fund's return on equity of -- beat Invesco Nasdaq Biotechnology ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital FBTFirst Trust NYSE Arca Biotechnology Index Fund-- -- -- IBBQInvesco Nasdaq Biotechnology ETF-- -- -- -
What do Analysts Say About FBT or IBBQ?
First Trust NYSE Arca Biotechnology Index Fund has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Nasdaq Biotechnology ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that First Trust NYSE Arca Biotechnology Index Fund has higher upside potential than Invesco Nasdaq Biotechnology ETF, analysts believe First Trust NYSE Arca Biotechnology Index Fund is more attractive than Invesco Nasdaq Biotechnology ETF.
Company Buy Ratings Hold Ratings Sell Ratings FBTFirst Trust NYSE Arca Biotechnology Index Fund0 0 0 IBBQInvesco Nasdaq Biotechnology ETF0 0 0 -
Is FBT or IBBQ More Risky?
First Trust NYSE Arca Biotechnology Index Fund has a beta of 0.732, which suggesting that the stock is 26.822% less volatile than S&P 500. In comparison Invesco Nasdaq Biotechnology ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock FBT or IBBQ?
First Trust NYSE Arca Biotechnology Index Fund has a quarterly dividend of $1.17 per share corresponding to a yield of 0.7%. Invesco Nasdaq Biotechnology ETF offers a yield of 1.11% to investors and pays a quarterly dividend of $0.06 per share. First Trust NYSE Arca Biotechnology Index Fund pays -- of its earnings as a dividend. Invesco Nasdaq Biotechnology ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios FBT or IBBQ?
First Trust NYSE Arca Biotechnology Index Fund quarterly revenues are --, which are smaller than Invesco Nasdaq Biotechnology ETF quarterly revenues of --. First Trust NYSE Arca Biotechnology Index Fund's net income of -- is lower than Invesco Nasdaq Biotechnology ETF's net income of --. Notably, First Trust NYSE Arca Biotechnology Index Fund's price-to-earnings ratio is -- while Invesco Nasdaq Biotechnology ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for First Trust NYSE Arca Biotechnology Index Fund is -- versus -- for Invesco Nasdaq Biotechnology ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income FBTFirst Trust NYSE Arca Biotechnology Index Fund-- -- -- -- IBBQInvesco Nasdaq Biotechnology ETF-- -- -- --
-
Which has Higher Returns FBT or IHI?
iShares US Medical Devices ETF has a net margin of -- compared to First Trust NYSE Arca Biotechnology Index Fund's net margin of --. First Trust NYSE Arca Biotechnology Index Fund's return on equity of -- beat iShares US Medical Devices ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital FBTFirst Trust NYSE Arca Biotechnology Index Fund-- -- -- IHIiShares US Medical Devices ETF-- -- -- -
What do Analysts Say About FBT or IHI?
First Trust NYSE Arca Biotechnology Index Fund has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares US Medical Devices ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that First Trust NYSE Arca Biotechnology Index Fund has higher upside potential than iShares US Medical Devices ETF, analysts believe First Trust NYSE Arca Biotechnology Index Fund is more attractive than iShares US Medical Devices ETF.
Company Buy Ratings Hold Ratings Sell Ratings FBTFirst Trust NYSE Arca Biotechnology Index Fund0 0 0 IHIiShares US Medical Devices ETF0 0 0 -
Is FBT or IHI More Risky?
First Trust NYSE Arca Biotechnology Index Fund has a beta of 0.732, which suggesting that the stock is 26.822% less volatile than S&P 500. In comparison iShares US Medical Devices ETF has a beta of 0.880, suggesting its less volatile than the S&P 500 by 12.031%.
-
Which is a Better Dividend Stock FBT or IHI?
First Trust NYSE Arca Biotechnology Index Fund has a quarterly dividend of $1.17 per share corresponding to a yield of 0.7%. iShares US Medical Devices ETF offers a yield of 0.46% to investors and pays a quarterly dividend of $0.03 per share. First Trust NYSE Arca Biotechnology Index Fund pays -- of its earnings as a dividend. iShares US Medical Devices ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios FBT or IHI?
First Trust NYSE Arca Biotechnology Index Fund quarterly revenues are --, which are smaller than iShares US Medical Devices ETF quarterly revenues of --. First Trust NYSE Arca Biotechnology Index Fund's net income of -- is lower than iShares US Medical Devices ETF's net income of --. Notably, First Trust NYSE Arca Biotechnology Index Fund's price-to-earnings ratio is -- while iShares US Medical Devices ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for First Trust NYSE Arca Biotechnology Index Fund is -- versus -- for iShares US Medical Devices ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income FBTFirst Trust NYSE Arca Biotechnology Index Fund-- -- -- -- IHIiShares US Medical Devices ETF-- -- -- --
-
Which has Higher Returns FBT or IYH?
iShares US Healthcare ETF has a net margin of -- compared to First Trust NYSE Arca Biotechnology Index Fund's net margin of --. First Trust NYSE Arca Biotechnology Index Fund's return on equity of -- beat iShares US Healthcare ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital FBTFirst Trust NYSE Arca Biotechnology Index Fund-- -- -- IYHiShares US Healthcare ETF-- -- -- -
What do Analysts Say About FBT or IYH?
First Trust NYSE Arca Biotechnology Index Fund has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares US Healthcare ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that First Trust NYSE Arca Biotechnology Index Fund has higher upside potential than iShares US Healthcare ETF, analysts believe First Trust NYSE Arca Biotechnology Index Fund is more attractive than iShares US Healthcare ETF.
Company Buy Ratings Hold Ratings Sell Ratings FBTFirst Trust NYSE Arca Biotechnology Index Fund0 0 0 IYHiShares US Healthcare ETF0 0 0 -
Is FBT or IYH More Risky?
First Trust NYSE Arca Biotechnology Index Fund has a beta of 0.732, which suggesting that the stock is 26.822% less volatile than S&P 500. In comparison iShares US Healthcare ETF has a beta of 0.582, suggesting its less volatile than the S&P 500 by 41.766%.
-
Which is a Better Dividend Stock FBT or IYH?
First Trust NYSE Arca Biotechnology Index Fund has a quarterly dividend of $1.17 per share corresponding to a yield of 0.7%. iShares US Healthcare ETF offers a yield of 1.18% to investors and pays a quarterly dividend of $0.16 per share. First Trust NYSE Arca Biotechnology Index Fund pays -- of its earnings as a dividend. iShares US Healthcare ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios FBT or IYH?
First Trust NYSE Arca Biotechnology Index Fund quarterly revenues are --, which are smaller than iShares US Healthcare ETF quarterly revenues of --. First Trust NYSE Arca Biotechnology Index Fund's net income of -- is lower than iShares US Healthcare ETF's net income of --. Notably, First Trust NYSE Arca Biotechnology Index Fund's price-to-earnings ratio is -- while iShares US Healthcare ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for First Trust NYSE Arca Biotechnology Index Fund is -- versus -- for iShares US Healthcare ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income FBTFirst Trust NYSE Arca Biotechnology Index Fund-- -- -- -- IYHiShares US Healthcare ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Pepsi Vs Coke Stock: Which Is Best?
Coca-Cola (NYSE:KO) and PepsiCo (NYSE:PEP) are two of the largest…
Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Stock Ideas
Buy
52
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Sell
48
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
52
RGC alert for Mar 19
Regencell Bioscience Holdings [RGC] is down 0.66% over the past day.
Sell
49
SRPT alert for Mar 19
Sarepta Therapeutics [SRPT] is up 8.72% over the past day.
Sell
46
CVNA alert for Mar 19
Carvana [CVNA] is up 5.74% over the past day.
